STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 101 filers reported holding STOKE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $20,630 | +40.4% | 1,527 | +10.5% | 0.00% | – |
| Q2 2023 | $14,690 | +27.6% | 1,382 | 0.0% | 0.00% | – |
| Q1 2023 | $11,512 | -9.7% | 1,382 | 0.0% | 0.00% | – |
| Q4 2022 | $12,755 | -25.0% | 1,382 | 0.0% | 0.00% | – |
| Q3 2022 | $17,000 | -39.3% | 1,382 | -36.3% | 0.00% | – |
| Q2 2022 | $28,000 | -91.2% | 2,170 | -83.7% | 0.00% | -100.0% |
| Q4 2021 | $319,000 | – | 13,313 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $475,340,000 | 79.82% |
| RTW INVESTMENTS, LP | 3,544,248 | $100,373,000 | 3.79% |
| Cormorant Asset Management, LP | 1,788,643 | $50,654,000 | 2.02% |
| RA Capital Management | 1,119,963 | $31,717,000 | 0.96% |
| Redmile Group, LLC | 1,020,778 | $28,908,000 | 0.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 256,380 | $7,261,000 | 0.60% |
| GILDER GAGNON HOWE & CO LLC | 1,826,890 | $51,738,000 | 0.54% |
| Perceptive Advisors | 671,978 | $19,030,000 | 0.38% |
| Casdin Capital, LLC | 130,000 | $3,682,000 | 0.34% |
| Granite Point Capital Management, L.P. | 13,200 | $374,000 | 0.06% |